Skip to content
Screener

Kestra Medical Technologies KMTS PP&E (Net)

PP&E (Net) at other companies

Abbott logo
AbbottABT
$12.81B+12.4%
Boston Scientific logo
Boston ScientificBSX
$4.06B+19.9%
Medtronic logo
MedtronicMDT
$7.42B+8.5%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$165.31M+18.3%
CeriBell, Inc. logo
CeriBell, Inc.CBLL
$1.76M-16.4%
Haemonetics logo
HaemoneticsHAE
$303.78M+5.9%

Other financials

Income statement

See full
Revenue$28.6M+66.2%
Gross profit$15.7M+105%
Operating income-$39.3M+18.4%
Net income-$38.8M+25.4%
EPS (diluted)-$0.67+57.3%

Balance sheet

See full
Cash & equivalents$99.7M-58.0%
Total debt$46.8M+5.6%
Total assets$358.5M+21.2%

Cash flow

See full
Operating cash flow-$18.7M+22.2%
CapEx$9.7M+30.8%
Free cash flow-$28.4M+9.7%

Valuation

See full
Market cap$1.55B+106%
Enterprise value$1.49B+151%
P/S16.3×+4.9×

Profitability

See full
Gross margin51.4%+10.9pp
Operating margin-141.6%-24.0pp
Net margin-138.4%-29.7pp
FCF margin-122.6%-26.1pp

Returns & leverage

See full
Current ratio4.4×-2.3×

Where this comes from

Reported directly by Kestra Medical Technologies in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 5:16 PM EDT
Fiscal year
FY2026
Accession
0001193125-26-303397
Line itemApril 30, 2026April 30, 2025
Right-of-use assets3,3642,078
Deposits1,7612,021
Restricted cash334334
Property and equipment, net59,09034,830
Other long-term assets5,7901,153
Total assets$358,465$295,744
Liabilities and Shareholders’ Equity
Current liabilities

Item 16. Form 10-K Summary.

FAQ

What is Kestra Medical Technologies's PP&E (net)?
Kestra Medical Technologies (KMTS) reported PP&E (net) of $59.09M in Q1 2026.
How has Kestra Medical Technologies's PP&E (net) changed year-over-year?
Kestra Medical Technologies's PP&E (net) increased by 69.7% year-over-year, from $34.83M to $59.09M.
What is the long-term trend for Kestra Medical Technologies's PP&E (net)?
Over 2 years (2024 to 2026), Kestra Medical Technologies's PP&E (net) has grown at a 50.5% compound annual growth rate (CAGR), from $26.11M to $59.09M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Kestra Medical Technologies's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude